Maryland’s first medicine price cap targets a widely used diabetes treatment Maryland’s Prescription Drug Affordability Board has set an upper payment limit for a commonly prescribed diabetes medication, marking the board’s first price cap under its authority. The move is designed to limit how…
Continue reading...
Continue reading...